Tomoki Ryu

769 total citations
53 papers, 525 citations indexed

About

Tomoki Ryu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Tomoki Ryu has authored 53 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 23 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Tomoki Ryu's work include Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (13 papers). Tomoki Ryu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (13 papers). Tomoki Ryu collaborates with scholars based in Japan, United States and South Korea. Tomoki Ryu's co-authors include Yoshiyuki Wada, Hirotomo Saitsu, Yuko Takami, Masaki Tateishi, Takanobu Hara, Hajime Matsushima, Shin Sasaki, Tomoki Todo, Yoshitaka Masutani and Kyousuke Kamada and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Tomoki Ryu

46 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoki Ryu Japan 14 314 185 157 104 99 53 525
Peter Hass Germany 14 194 0.6× 80 0.4× 128 0.8× 99 1.0× 170 1.7× 53 583
Debra Brody United States 10 31 0.1× 296 1.6× 317 2.0× 335 3.2× 161 1.6× 19 697
Shaihong Zhu China 11 87 0.3× 63 0.3× 108 0.7× 95 0.9× 19 0.2× 24 511
Kiyoshi Kakuda Japan 9 63 0.2× 86 0.5× 176 1.1× 17 0.2× 81 0.8× 13 412
Saburo Nakamura Japan 12 93 0.3× 70 0.4× 87 0.6× 37 0.4× 16 0.2× 43 451
Dongqing Wang China 14 36 0.1× 39 0.2× 59 0.4× 55 0.5× 145 1.5× 28 527
N Miyazawa Japan 14 28 0.1× 63 0.3× 110 0.7× 38 0.4× 101 1.0× 29 501
Pei‐Min Hsieh Taiwan 11 103 0.3× 137 0.7× 79 0.5× 112 1.1× 9 0.1× 19 352
Seok-ki Kim South Korea 11 9 0.0× 89 0.5× 167 1.1× 93 0.9× 172 1.7× 22 574
Junpeng Ma China 11 73 0.2× 55 0.3× 105 0.7× 56 0.5× 12 0.1× 29 403

Countries citing papers authored by Tomoki Ryu

Since Specialization
Citations

This map shows the geographic impact of Tomoki Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Ryu more than expected).

Fields of papers citing papers by Tomoki Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Ryu. The network helps show where Tomoki Ryu may publish in the future.

Co-authorship network of co-authors of Tomoki Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Ryu. A scholar is included among the top collaborators of Tomoki Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Ryu. Tomoki Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, & Hirotomo Saitsu. (2022). Oncological Outcomes of Operative Microwave Ablation for Intermediate Stage Hepatocellular Carcinoma: Experience in 246 Consecutive Patients. Journal of Gastrointestinal Surgery. 26(6). 1178–1186. 2 indexed citations
2.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, Shin Sasaki, & Hirotomo Saitsu. (2021). Predictive impact of the prognostic nutritional index in early-staged hepatocellular carcinoma after operative microwave ablation. Asian Journal of Surgery. 45(1). 202–207. 7 indexed citations
3.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, & Hirotomo Saitsu. (2021). Operative Microwave Ablation for Hepatocellular Carcinoma Within 3 cm and 3 Nodules: Experience in 559 Patients. Journal of Gastrointestinal Surgery. 26(3). 615–622. 6 indexed citations
4.
Sasaki, Shin, Yuko Takami, Yoshiyuki Wada, et al.. (2020). Glomus tumor of the duodenum: a rare case report. SHILAP Revista de lepidopterología. 6(1). 305–305. 5 indexed citations
5.
Sato, Yo, Takanobu Hara, Yuko Takami, et al.. (2019). Conversion surgery for initially unresectable carcinoma of the ampulla of Vater following pathological complete response to chemotherapy: a case report. SHILAP Revista de lepidopterología. 5(1). 122–122.
6.
Ryu, Tomoki & Hirotomo Saitsu. (2019). ASO Author Reflections: 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma. Annals of Surgical Oncology. 26(S3). 808–809.
7.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, et al.. (2019). Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy. HPB. 22(3). 461–469. 16 indexed citations
8.
9.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, et al.. (2017). Oncological outcomes after hepatic resection and/or surgical microwave ablation for liver metastasis from gastric cancer. Asian Journal of Surgery. 42(1). 100–105. 25 indexed citations
10.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, et al.. (2017). Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A. Journal of Gastrointestinal Surgery. 21(6). 957–966. 21 indexed citations
12.
Wada, Yoshiyuki, et al.. (2016). Efficacy of surgical treatment using microwave coagulo-necrotic therapy for unresectable multiple colorectal liver metastases. OncoTargets and Therapy. 9. 937–937. 11 indexed citations
14.
Ryu, Tomoki, Yuko Takami, Norifumi Tsutsumi, et al.. (2016). Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism. Surgery Today. 47(5). 548–554. 15 indexed citations
15.
Takami, Yuko, Susumu Eguchi, Masaki Tateishi, et al.. (2016). A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment. Hepatology International. 10(5). 799–806. 19 indexed citations
16.
Ryu, Tomoki, Yuko Takami, Masaki Tateishi, Yoshiyuki Wada, & Hirotomo Saitsu. (2012). Strategies for the treatment of liver metastases from gastric cancer: hepatic resection and microwave coagulo-necrotic therapy (MCN). Journal of Microwave Surgery. 30(0). 97–102. 1 indexed citations
17.
Ryu, Tomoki, Yuko Takami, Masaki Tateishi, Yoshiyuki Wada, & Hirotomo Saitsu. (2012). Efficacy of COX-2 inhibitor, Meloxicam, for recurrent hepatocellular carcinoma after curative treatment. Kanzo. 53(11). 781–783. 1 indexed citations
18.
Ryu, Tomoki, Yuko Takami, Yoshiyuki Wada, & Hirotomo Saitsu. (2011). A case of synchronous double cancer of the common bile duct and papilla of vater. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72(12). 3135–3139.
19.
Takami, Yuko, et al.. (2008). The strategy for the treatment of hepatocellular carcinoma: Hr and/or MCN. Journal of Microwave Surgery. 26. 73–78. 2 indexed citations
20.
Hayakawa, Tetsu, et al.. (1978). Caudal projections of the habenular nuclei in cats: fibers from the lateral habenular nucleus.. PubMed. 28(3-4). 229–43. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026